AstraZeneca: Crestor para niños...

LONDON (MarketWatch) -- The U.S. Food and Drug Administration has approved the use of Crestor in patients aged 10 to 17 with heterozygous familial hypercholesterolemia when diet therapy fails to reduce elevated cholesterol.

AstraZeneca said it doesn't plan to actively promote the indication. (Ver...)

Ver Crestor